Anti-Cancer Agents in Medicinal Chemistry
Title:Meet Our Sectional Editor
Volume: 18 Issue: 12
Author(s): Alexander A. Shtil
Affiliation:
Export Options
About this article
Cite this article as:
Shtil A. Alexander , Meet Our Sectional Editor, Anti-Cancer Agents in Medicinal Chemistry 2018; 18 (12) . https://dx.doi.org/10.2174/187152061812190112094937
DOI https://dx.doi.org/10.2174/187152061812190112094937 |
Print ISSN 1871-5206 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5992 |
23
2
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Advances in Noninvasive Pulmonary Gene Therapy
Current Drug Delivery Nutrigenomics for Global Health: Ethical Challenges for Underserved Populations
Current Pharmacogenomics and Personalized Medicine Saccharomyces Cerevisiae as a Genetic Model in Anticancer Therapy
Current Pharmacogenomics Intracellular Logistics of BST-2/Tetherin
Current HIV Research Anti-Angiogenic Cancer Therapy Updates
Current Molecular Medicine From Nanotechnology to Nanomedicine: Applications to Cancer Research
Current Molecular Medicine Elevated Microsatellite Alterations at Selected Tetranucleotide Repeats (EMAST) and Microsatellite Instability in Patients with Colorectal Cancer and Its Clinical Features
Current Molecular Medicine Advances in Reprogramming to Pluripotency
Current Stem Cell Research & Therapy Androgen Receptor Antagonists in the Treatment of Prostate Cancer
Clinical Immunology, Endocrine & Metabolic Drugs (Discontinued) Working Hypothesis: Elimination of Cancer Stem Cells in Solid Tumors by Immuno-Gene Therapy Using Cancer Vaccines and Created-Inhibitory RNA
Current Cancer Therapy Reviews Bone Metastatic Disease: Taking Aim at New Therapeutic Targets
Current Medicinal Chemistry Radiobromine-Labelled Tracers for Positron Emission Tomography: Possibilities and Pitfalls
Current Radiopharmaceuticals Pyrrolidino Analogues of Gefitinib with Improved EGFR Inhibition, Cancer Cell Cytotoxicity, and Pharmacokinetic Properties
Anti-Cancer Agents in Medicinal Chemistry Better Targeting Melanoma: Options Beyond Surgery and Conventional Chemotherapy
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Inhibition of DNA Polymerase λ Suppresses 12-O-Tetradecanoylphorbol- 13-Acetate-Induced Inflammation
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents Vitamin E–TPGS Stabilized Self-Assembled Tripeptide Nanostructures for Drug Delivery
Current Topics in Medicinal Chemistry The Coordinated Role of CYP450 Enzymes and P-gp in Determining Cancer Resistance to Chemotherapy
Current Drug Metabolism Preparation and Characterization of Bifunctional Nanoparticles of Vitamin E TPGS-emulsified PLGA-PEG-FOL Containing Deferasirox
Nanoscience & Nanotechnology-Asia In Silico Identification of Small Molecule Mimetics of the Pro-Apoptotic BH3-Helix
Letters in Drug Design & Discovery Disposition of Pharmacologically Active Dietary Isoflavones in Biological Systems
Current Drug Metabolism